Short Interest in Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Drops By 25.6%

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) saw a significant drop in short interest in February. As of February 28th, there was short interest totalling 30,200 shares, a drop of 25.6% from the February 13th total of 40,600 shares. Based on an average daily volume of 765,800 shares, the days-to-cover ratio is presently 0.0 days.

Ono Pharmaceutical Price Performance

OTCMKTS OPHLY traded up $0.01 during trading on Friday, hitting $3.68. The company’s stock had a trading volume of 154,657 shares, compared to its average volume of 464,018. The business’s 50 day simple moving average is $3.46 and its 200-day simple moving average is $3.88. Ono Pharmaceutical has a fifty-two week low of $3.21 and a fifty-two week high of $5.67.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.